Current Gene Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.1 | Q2 | 75.0% | 0.706 | Q2 | 73.1% |
| 2024 | 3.3 | Q2 | 66.5% | 0.673 | Q2 | 72.3% |
| 2023 | 3.8 | Q2 | 77.9% | 0.674 | Q2 | 74.6% |
| 2022 | 3.6 | Q2 | 65.4% | 0.564 | Q2 | 70.1% |
| 2021 | 4.7 | Q2 | 73.6% | 0.656 | Q2 | 75.7% |
| 2020 | — | — | 0.704 | Q2 | 76.3% | |
| 2019 | — | — | 0.782 | Q2 | 79.8% | |
| 2018 | — | — | 1.008 | Q1 | 84.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1566-5232
ISSN
1875-5631
country
AEcoverage
2001-2025